JPMorgan Chase & Co’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-250,000
| Closed | -$2.53M | – | 6391 |
|
|
2023
Q1 | $2.53M | Buy |
250,000
+175,000
| +233% | +$1.77M | ﹤0.01% | 2899 |
|
|
2022
Q4 | $750K | Sell |
75,000
-24,500
| -25% | -$245K | ﹤0.01% | 3527 |
|
|
2022
Q3 | $964K | Sell |
99,500
-50,500
| -34% | -$489K | ﹤0.01% | 3385 |
|
|
2022
Q2 | $1.45M | Hold |
150,000
| – | – | ﹤0.01% | 3234 |
|
|
2022
Q1 | $1.46M | Sell |
150,000
-139,000
| -48% | -$1.35M | ﹤0.01% | 3392 |
|
|
2021
Q4 | $2.84M | Sell |
289,000
-10,349
| -3% | -$102K | ﹤0.01% | 2976 |
|
|
2021
Q3 | $2.94M | Buy |
+299,349
| New | +$2.94M | ﹤0.01% | 2930 |
|